SUPN logo

Supernus Pharmaceuticals (SUPN) Operating profit

annual operating profit:

$75.56M+$62.15M(+463.72%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SUPN annual operating income is $75.56 million, with the most recent change of +$62.15 million (+463.72%) on December 31, 2024.
  • During the last 3 years, SUPN annual operating profit has fallen by -$3.94 million (-4.96%).
  • SUPN annual operating profit is now -56.97% below its all-time high of $175.60 million, reached on December 31, 2020.

Performance

SUPN Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

quarterly operating profit:

-$2.60M-$24.36M(-111.93%)
March 31, 2025

Summary

  • As of today (May 29, 2025), SUPN quarterly operating income is -$2.60 million, with the most recent change of -$24.36 million (-111.93%) on March 31, 2025.
  • Over the past year, SUPN quarterly operating profit has increased by +$1.65 million (+38.89%).
  • SUPN quarterly operating profit is now -104.61% below its all-time high of $56.34 million, reached on September 30, 2020.

Performance

SUPN quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

TTM operating profit:

$77.21M+$1.65M(+2.19%)
March 31, 2025

Summary

  • As of today (May 29, 2025), SUPN TTM operating income is $77.21 million, with the most recent change of +$1.65 million (+2.19%) on March 31, 2025.
  • Over the past year, SUPN TTM operating profit has increased by +$71.58 million (+1272.34%).
  • SUPN TTM operating profit is now -56.03% below its all-time high of $175.60 million, reached on December 31, 2020.

Performance

SUPN TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

SUPN Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+463.7%+38.9%+1272.3%
3 y3 years-5.0%-198.6%+13.7%
5 y5 years-49.1%-109.0%-49.3%

SUPN Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5.0%+463.7%-106.5%+84.5%at high+1272.3%
5 y5-year-57.0%+463.7%-104.6%+84.5%-56.0%+1272.3%
alltimeall time-57.0%+222.0%-104.6%+86.6%-56.0%+222.0%

SUPN Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$2.60M(-111.9%)
$77.21M(+2.2%)
Dec 2024
$75.56M(+463.7%)
$21.76M(-45.4%)
$75.56M(+3.8%)
Sep 2024
-
$39.83M(+118.7%)
$72.78M(+79.1%)
Jun 2024
-
$18.21M(-528.8%)
$40.64M(+622.3%)
Mar 2024
-
-$4.25M(-122.4%)
$5.63M(-58.0%)
Dec 2023
$13.40M(-70.6%)
$18.99M(+147.2%)
$13.40M(-49.1%)
Sep 2023
-
$7.68M(-145.7%)
$26.34M(+49.5%)
Jun 2023
-
-$16.80M(-576.0%)
$17.63M(-62.1%)
Mar 2023
-
$3.53M(-88.9%)
$46.51M(+2.0%)
Dec 2022
$45.61M(-42.6%)
$31.93M(-3179.1%)
$45.61M(+118.2%)
Sep 2022
-
-$1.04M(-108.6%)
$20.90M(-61.7%)
Jun 2022
-
$12.09M(+359.3%)
$54.62M(-19.6%)
Mar 2022
-
$2.63M(-63.5%)
$67.90M(-14.6%)
Dec 2021
$79.50M(-54.7%)
$7.22M(-77.9%)
$79.50M(-32.0%)
Sep 2021
-
$32.68M(+28.9%)
$116.98M(-16.8%)
Jun 2021
-
$25.36M(+78.2%)
$140.63M(-12.6%)
Mar 2021
-
$14.23M(-68.2%)
$160.82M(-8.4%)
Dec 2020
$175.60M(+18.2%)
$44.70M(-20.7%)
$175.60M(+2.3%)
Sep 2020
-
$56.34M(+23.7%)
$171.72M(+10.7%)
Jun 2020
-
$45.55M(+57.0%)
$155.10M(+1.9%)
Mar 2020
-
$29.01M(-28.9%)
$152.16M(+2.4%)
Dec 2019
$148.57M(+2.9%)
$40.82M(+2.7%)
$148.57M(+0.7%)
Sep 2019
-
$39.73M(-6.7%)
$147.61M(+1.6%)
Jun 2019
-
$42.60M(+67.5%)
$145.36M(+5.0%)
Mar 2019
-
$25.43M(-36.2%)
$138.48M(-4.1%)
Dec 2018
$144.44M(+45.1%)
$39.85M(+6.4%)
$144.44M(+4.0%)
Sep 2018
-
$37.48M(+4.9%)
$138.93M(+12.2%)
Jun 2018
-
$35.72M(+13.8%)
$123.80M(+8.5%)
Mar 2018
-
$31.39M(-8.6%)
$114.15M(+14.7%)
Dec 2017
$99.54M
$34.34M(+53.7%)
$99.54M(+22.1%)
DateAnnualQuarterlyTTM
Sep 2017
-
$22.34M(-14.3%)
$81.49M(+3.2%)
Jun 2017
-
$26.07M(+55.3%)
$78.99M(+22.3%)
Mar 2017
-
$16.79M(+3.0%)
$64.57M(+19.1%)
Dec 2016
$54.22M(+160.1%)
$16.30M(-17.9%)
$54.22M(+18.4%)
Sep 2016
-
$19.84M(+70.4%)
$45.80M(+47.5%)
Jun 2016
-
$11.64M(+80.9%)
$31.05M(+33.6%)
Mar 2016
-
$6.44M(-18.3%)
$23.25M(+11.5%)
Dec 2015
$20.84M(-494.9%)
$7.88M(+55.0%)
$20.84M(+15.2%)
Sep 2015
-
$5.08M(+32.3%)
$18.09M(+47.5%)
Jun 2015
-
$3.84M(-4.7%)
$12.27M(+0.7%)
Mar 2015
-
$4.03M(-21.3%)
$12.18M(-330.8%)
Dec 2014
-$5.28M(-91.5%)
$5.13M(-796.3%)
-$5.28M(-75.7%)
Sep 2014
-
-$736.00K(-119.6%)
-$21.76M(-43.0%)
Jun 2014
-
$3.76M(-128.0%)
-$38.20M(-33.5%)
Mar 2014
-
-$13.42M(+18.2%)
-$57.43M(-7.2%)
Dec 2013
-$61.92M(+46.8%)
-$11.36M(-33.9%)
-$61.92M(-2.2%)
Sep 2013
-
-$17.18M(+11.0%)
-$63.30M(+8.4%)
Jun 2013
-
-$15.48M(-13.6%)
-$58.42M(+11.9%)
Mar 2013
-
-$17.91M(+40.5%)
-$52.20M(+23.8%)
Dec 2012
-$42.17M(+11.7%)
-$12.74M(+3.7%)
-$42.17M(+6.3%)
Sep 2012
-
-$12.29M(+32.8%)
-$39.67M(+6.4%)
Jun 2012
-
-$9.26M(+17.5%)
-$37.29M(+2.4%)
Mar 2012
-
-$7.88M(-23.1%)
-$36.43M(-3.5%)
Dec 2011
-$37.75M(-5.9%)
-$10.24M(+3.3%)
-$37.75M(-19.5%)
Sep 2011
-
-$9.91M(+18.1%)
-$46.90M(+26.8%)
Jun 2011
-
-$8.40M(-8.7%)
-$36.98M(+29.4%)
Mar 2011
-
-$9.20M(-52.6%)
-$28.59M(+47.4%)
Dec 2010
-$40.12M(-1099.1%)
-$19.39M(+41.1%)
-$19.39M(+41.1%)
Dec 2009
$4.02M(-115.5%)
-$13.74M
-$13.74M
Dec 2008
-$25.86M(+35.8%)
-
-
Dec 2007
-$19.05M
-
-

FAQ

  • What is Supernus Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual operating profit year-on-year change?
  • What is Supernus Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly operating profit year-on-year change?
  • What is Supernus Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals TTM operating profit year-on-year change?

What is Supernus Pharmaceuticals annual operating income?

The current annual operating profit of SUPN is $75.56M

What is the all time high annual operating profit for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual operating income is $175.60M

What is Supernus Pharmaceuticals annual operating profit year-on-year change?

Over the past year, SUPN annual operating income has changed by +$62.15M (+463.72%)

What is Supernus Pharmaceuticals quarterly operating income?

The current quarterly operating profit of SUPN is -$2.60M

What is the all time high quarterly operating profit for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly operating income is $56.34M

What is Supernus Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, SUPN quarterly operating income has changed by +$1.65M (+38.89%)

What is Supernus Pharmaceuticals TTM operating income?

The current TTM operating profit of SUPN is $77.21M

What is the all time high TTM operating profit for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high TTM operating income is $175.60M

What is Supernus Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, SUPN TTM operating income has changed by +$71.58M (+1272.34%)
On this page